NIH-funded research R21 grant

Understanding how CREB affects communication between brain cells in Alzheimer's disease

Official title: Regulation and functions of CREB in excitatory synapses of hippocampal neurons

Funded at Georgetown University · NIH-11042200 · Data updated 2026-11-12

This study is looking at how a protein called CREB helps brain cells talk to each other in the hippocampus, especially in people with Alzheimer's, to find new ways to help improve memory and learning.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionGeorgetown University
NIH-funded
Lab location1 site (Washington, United States)
Project startMarch 1, 2024
Project endFebruary 28, 2026
Funding year2025
Award (this year)$191,920
NIH project number5R21NS136976-02
Project IDNIH-11042200 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those experiencing early signs of cognitive impairment.

Less likely to help

Patients with other forms of dementia unrelated to Alzheimer's may not receive benefit from this research.

What this research studies

This research investigates the role of a protein called CREB in the communication between neurons in the hippocampus, particularly in the context of Alzheimer's disease. By examining how CREB influences synaptic plasticity, which is the ability of synapses to strengthen or weaken over time, the research aims to uncover new mechanisms that could be targeted for therapeutic interventions. The study will utilize advanced techniques to observe changes in neuron behavior and gene expression in response to different stimuli. Patients may benefit from insights gained about how synaptic dysfunction contributes to Alzheimer's disease progression.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating or preventing cognitive decline in Alzheimer's disease.

How similar studies have gone: Previous research has shown promising results in understanding synaptic mechanisms in Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Georgetown University
    Washington, United States
    Active

Researchers

  • Principal investigator: Pak, Daniel T — Georgetown University
  • Study coordinator: Pak, Daniel T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.